NFKB1 and lung carcinoma: Collectively, these findings indicate that TGFβ activates NF-kB through p38 MAPK in lung cancer cells, and SC-1 inhibits TGFβ-mediated IL-6 secretion via the p38–NF-kB signaling cascade.